Literature DB >> 9844922

Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells.

A M Ibrado1, C N Kim, K Bhalla.   

Abstract

The antimicrotubule anticancer drug, Taxol, suppresses microtubule dynamics, causes mitotic arrest, and induces caspase-3 cleavage and activity resulting in apoptosis of human AML HL-60 cells. Caspase-3 cleavage is triggered by the mitochondrial release and cytosolic accumulation of the electron transfer protein, cytochrome c (cyt c). Taxol-induced G2/M transition is mediated by p34(cdc-2) (CDK1) which, if prematurely activated, may also trigger apoptosis. In the present studies following S-phase synchronization and release, HL-60 cells with enforced expression of the bcl-xL (HL-60/Bcl-xL) and/or neomycin resistance gene (HL-60/neo) were exposed to Taxol to examine CDK1-related cell-cycle events and the cyt c-triggered molecular cascade of apoptosis. At various time-intervals after Taxol treatment, immunoblot analyses of cyclin B1 and CDK1 levels were performed. In addition, the in vitro histone H1 kinase activity of immunoprecipitated CDK1 and its tyrosine phosphorylation status (by anti-phosphotyrosine immunoblot analysis) were determined. Data presented here show that, while Taxol-induced peak CDK1 kinase activity occurs earlier in HL-60/neo cells, there are no significant differences in cyclin B1 accumulation, tyrosine dephosphorylation of CDK1, and mitotic arrest of Taxol-treated HL-60/neo vs HL-60/Bcl-xL cells. Taxol-induced CDK1 activation and mitosis preceded the cytosolic accumulation (approximately six-fold) of cyt c. The latter event was blocked by Bcl-xL overexpression but not by inhibitors of caspase-3. Although the caspase inhibitors and high Bcl-xL levels inhibited caspase-3 cleavage and activity, they did not significantly affect Taxol-induced CDK1 activation or mitotic arrest. These findings indicate that Bcl-xL overexpression does not affect Taxol-induced CDK1 activity leading to G2/M transition, which temporally precedes the cytosolic cyt c-mediated cleavage and activity of caspase-3 and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844922     DOI: 10.1038/sj.leu.2401218

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  18 in total

1.  GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis.

Authors:  F Essmann; T Wieder; A Otto; E C Müller; B Dörken; P T Daniel
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  Caspase-mediated specific cleavage of BubR1 is a determinant of mitotic progression.

Authors:  Mijin Kim; Katie Murphy; Fang Liu; Sharon E Parker; Melissa L Dowling; Wesley Baff; Gary D Kao
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

3.  Enhanced antitumor activity of irofulven in combination with antimitotic agents.

Authors:  Michael J Kelner; Trevor C McMorris; Rafael J Rojas; Nicole A Trani; Tami R Velasco; Leita A Estes; Pharnuk Suthipinijtham
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

4.  A novel microtubule inhibitor, MT3-037, causes cancer cell apoptosis by inducing mitotic arrest and interfering with microtubule dynamics.

Authors:  Ling-Chu Chang; Yung-Luen Yu; Min-Tsang Hsieh; Sheng-Hung Wang; Ruey-Hwang Chou; Wei-Chien Huang; Hui-Yi Lin; Hsin-Yi Hung; Li-Jiau Huang; Sheng-Chu Kuo
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

5.  Tripeptidyl peptidase II in human oral squamous cell carcinoma.

Authors:  Katsuya Usukura; Atsushi Kasamatsu; Atsushi Okamoto; Yukinao Kouzu; Morihiro Higo; Hirofumi Koike; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-18       Impact factor: 4.553

6.  Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b.

Authors:  Regina Maushagen; Stefan Reers; Ann-Christin Pfannerstill; Angelina Hahlbrock; Roland Stauber; Ramtin Rahmanzadeh; Dirk Rades; Ralph Pries; Barbara Wollenberg
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-01       Impact factor: 4.553

7.  Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma.

Authors:  Stefan K Zöllner; Saravana P Selvanathan; Garrett T Graham; Ryan M T Commins; Sung Hyeok Hong; Eric Moseley; Sydney Parks; Jessica N Haladyna; Hayriye V Erkizan; Uta Dirksen; Michael D Hogarty; Aykut Üren; Jeffrey A Toretsky
Journal:  Sci Signal       Date:  2017-10-03       Impact factor: 8.192

8.  Role of cyclin B1/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole.

Authors:  Hye Joung Choi; Masayuki Fukui; Bao Ting Zhu
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

9.  Vorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cells.

Authors:  Luca A Petruccelli; Daphné Dupéré-Richer; Filippa Pettersson; Hélène Retrouvey; Sophia Skoulikas; Wilson H Miller
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

10.  A short caspase-3 isoform inhibits chemotherapy-induced apoptosis by blocking apoptosome assembly.

Authors:  Frédérique Végran; Romain Boidot; Eric Solary; Sarab Lizard-Nacol
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.